Nevertheless, considering that obesity and type 2 diabetes are risk factors of “sporadic” AD, we should examine the effect of the BACE1/AP-2/clathrin complex on the pathology of sporadic AD in future studies. Here, BACE1 is linked to Alzheimer disease.